41
Participants
Start Date
July 31, 2012
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
ENMD-2076
250 mg per day in oral capsules in 28 day continuous cycles
Inidiana University Melvin and Bren Simon Cancer Center, Indianapolis
University of Colorado Cancer Center, Aurora
Cancer Hospital of Chinese Academy of Medical Science, Beijing
Lead Sponsor
University of Colorado, Denver
OTHER
Indiana University Melvin and Bren Simon Cancer Center
OTHER
CASI Pharmaceuticals, Inc.
INDUSTRY